Bingyan Guo

1.0k total citations
45 papers, 801 citations indexed

About

Bingyan Guo is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Bingyan Guo has authored 45 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Bingyan Guo's work include Cardiac Fibrosis and Remodeling (8 papers), Cardiovascular Function and Risk Factors (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Bingyan Guo is often cited by papers focused on Cardiac Fibrosis and Remodeling (8 papers), Cardiovascular Function and Risk Factors (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Bingyan Guo collaborates with scholars based in China, United States and Taiwan. Bingyan Guo's co-authors include Vijay Yechoor, Ke Ma, Somik Chatterjee, Suyun Liu, Jeongkyung Lee, Hong Zhou, Willa A. Hsueh, Laurie J. Minze, Lifei Li and Yongjun Li and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Agricultural and Food Chemistry and The FASEB Journal.

In The Last Decade

Bingyan Guo

43 papers receiving 792 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingyan Guo China 14 349 264 221 156 120 45 801
Lucile Dollet Sweden 14 568 1.6× 519 2.0× 94 0.4× 77 0.5× 67 0.6× 16 1.0k
Christina D. Camell United States 13 301 0.9× 461 1.7× 52 0.2× 126 0.8× 53 0.4× 26 1.1k
Alicia Mayeuf-Louchart France 15 334 1.0× 213 0.8× 153 0.7× 28 0.2× 30 0.3× 19 698
Eun‐Kyoung Kim South Korea 14 270 0.8× 141 0.5× 58 0.3× 61 0.4× 54 0.5× 42 767
Gholamreza Fazeli Germany 15 277 0.8× 105 0.4× 35 0.2× 33 0.2× 74 0.6× 27 613
Cristina Caccioppoli Italy 15 415 1.2× 222 0.8× 39 0.2× 79 0.5× 80 0.7× 18 850
Carlos Castaño Spain 14 767 2.2× 339 1.3× 172 0.8× 108 0.7× 415 3.5× 21 1.2k
Beatriz de Luxán‐Delgado Spain 15 249 0.7× 218 0.8× 89 0.4× 20 0.1× 102 0.8× 27 736
Jessica Segalés Spain 15 1.4k 3.9× 582 2.2× 39 0.2× 56 0.4× 112 0.9× 16 1.7k
Tadakatsu Inagaki Japan 15 266 0.8× 214 0.8× 58 0.3× 135 0.9× 46 0.4× 36 785

Countries citing papers authored by Bingyan Guo

Since Specialization
Citations

This map shows the geographic impact of Bingyan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyan Guo more than expected).

Fields of papers citing papers by Bingyan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingyan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyan Guo. The network helps show where Bingyan Guo may publish in the future.

Co-authorship network of co-authors of Bingyan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Bingyan Guo. A scholar is included among the top collaborators of Bingyan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingyan Guo. Bingyan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Xiaohua, et al.. (2024). Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress. International Immunopharmacology. 142(Pt B). 113134–113134. 4 indexed citations
2.
Liu, Jingbo, Bingyan Guo, Zhengping Li, et al.. (2024). Novel Evodiamine-Based Sulfonamide Derivatives as Potent Insecticide Candidates Targeting Insect Ryanodine Receptors. Journal of Agricultural and Food Chemistry. 72(2). 1292–1301. 5 indexed citations
3.
Zhang, Liang, et al.. (2024). Ceramides and pro-inflammatory cytokines for the prediction of acute coronary syndrome: a multi-marker approach. BMC Cardiovascular Disorders. 24(1). 47–47. 3 indexed citations
4.
Guo, Xiaohua, et al.. (2024). Neuregulin-4 alleviates isoproterenol (ISO)-induced cardial remodeling by inhibiting inflammation and apoptosis via AMPK/NF-κB pathway. International Immunopharmacology. 143(Pt 2). 113301–113301. 5 indexed citations
5.
Chen, Zhiyan, Bingyan Guo, Zhe Liu, et al.. (2023). Speckle-tracking echocardiography provides sensitive measurements of subtle early alterations associated with cardiac dysfunction in T2DM rats. BMC Cardiovascular Disorders. 23(1). 266–266. 2 indexed citations
6.
7.
Guo, Bingyan, et al.. (2023). BERT‐TriF: An inductive short text classification model for power equipment defect records. Engineering Reports. 5(10). 1 indexed citations
8.
9.
Wang, Lijie, et al.. (2022). Effect of Secreted Frizzled-Related Protein 5 in Mice with Heart Failure. Evidence-based Complementary and Alternative Medicine. 2022. 1–8. 1 indexed citations
10.
Li, Yong, Rong Yang, Bingyan Guo, et al.. (2019). Exosomal miR-301 derived from mesenchymal stem cells protects myocardial infarction by inhibiting myocardial autophagy. Biochemical and Biophysical Research Communications. 514(1). 323–328. 55 indexed citations
11.
Wang, Xin, Bingyan Guo, Liyan Zhao, et al.. (2018). Detection and genetic characterization of kobuvirus in cats: The first molecular evidence from Northeast China. Infection Genetics and Evolution. 68. 58–67. 13 indexed citations
12.
Qiao, Li, Bingyan Guo, Hui Zhang, et al.. (2017). The clock gene, brain and muscle Arnt-like 1, regulates autophagy in high glucose-induced cardiomyocyte injury. Oncotarget. 8(46). 80612–80624. 12 indexed citations
13.
Guo, Bingyan & Yongjun Li. (2015). GW26-e4592 Implication of C1q/TNF-related protein-12(CTRP-12) in patients with coronary artery disease. Journal of the American College of Cardiology. 66(16). C67–C67. 1 indexed citations
14.
Yang, Rong, Liang Chang, Bingyan Guo, et al.. (2014). Compound Danshen Dripping Pill Pretreatment to Prevent Contrast‐Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Evidence-based Complementary and Alternative Medicine. 2014(1). 256268–256268. 12 indexed citations
15.
Liu, Suyun, et al.. (2014). Chemerin Induces Insulin Resistance in Rat Cardiomyocytes in Part through the ERK1/2 Signaling Pathway. Pharmacology. 94(5-6). 259–264. 29 indexed citations
16.
Jin, Xin, Bingyan Guo, & Yongjun Li. (2014). GW25-e4266 Action and Mechanism of Secreted Frizzled-Related Protein 5 in Cardiomyocyte Hypertrophy. Journal of the American College of Cardiology. 64(16). C43–C43. 1 indexed citations
17.
Guo, Bingyan & Yongjun Li. (2014). GW25-e4168 Dipeptidyl peptidase (DPP) -4 inhibitor exhibits anti-apoptosis effects in isoproterenol-induced myocardial infarcted rats by inhibiting oxidative stress. Journal of the American College of Cardiology. 64(16). C43–C43. 1 indexed citations
18.
Guo, Bingyan, et al.. (2011). Angiotensin II Upregulation of Cardiomyocyte Adiponectin Production Is Nitric Oxide/Cyclic GMP Dependent. The American Journal of the Medical Sciences. 341(5). 350–355. 8 indexed citations
19.
Zhou, Hong, et al.. (2011). Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts. Clinical and Experimental Pharmacology and Physiology. 38(6). 387–394. 31 indexed citations
20.
Guo, Bingyan, et al.. (2011). Telmisartan attenuates isoproterenol-induced cardiac remodeling in rats via regulation of cardiac adiponectin expression. Acta Pharmacologica Sinica. 32(4). 449–455. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucile Dollet Breakdown of academic impact, for papers by Christina D. Camell Breakdown of academic impact, for papers by Alicia Mayeuf-Louchart Breakdown of academic impact, for papers by Eun‐Kyoung Kim Breakdown of academic impact, for papers by Gholamreza Fazeli Breakdown of academic impact, for papers by Cristina Caccioppoli Breakdown of academic impact, for papers by Carlos Castaño Breakdown of academic impact, for papers by Beatriz de Luxán‐Delgado Breakdown of academic impact, for papers by Jessica Segalés Breakdown of academic impact, for papers by Tadakatsu Inagaki
Rankless by CCL
2026